Multivariate analysis of determinants of bacterial contamination of whole-blood donations
A case-control study of risk factors associated with human T-cell lymphotrophic virus type-I seropositivity in blood donors from Guadeloupe, French West Indies
Quality control of leucoreduced cellular blood components in France
Donor selection in Japan
Evaluation of the HemoCue plasma haemoglobin analyser for assessing haemolysis in red cell concentrates during storage
Recent experience with human immunodeficiency virus transmission by cellular blood products in Germany
Regarding ‘Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay’ by Salama et al.
Regarding ‘Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay’ by Salama et al.
Dosage in neutrophil transfusions
Dosage in neutrophil transfusions
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 1
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 2
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 3
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 4
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 5
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 6
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 7
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 8
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: Response 9
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
DIARY OF EVENTS